- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03330873
The Efficacy and Safety of Disposable Balloon Uterine Stent in Patients With Asherman Syndrome
October 31, 2017 updated by: Beijing Obstetrics and Gynecology Hospital
Randomized, Controlled Trial to Assess the Efficacy of Disposable Balloon Uterine Stent and Foley Catheter in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis
Asherman's syndrome is characterized by the presence of intrauterine adhesions (IUA) as well as symptoms such as amenorrhea, hypomenorrhea, pelvic pain, and infertility.
The gold standard for the treatment of intrauterine adhesions is hysteroscopic intrauterine adhesions.
The recurrence of intrauterine adhesions is a major challenge in clinical practice.
The isolation of barriers in the uterine cavity may be a measure to reduce postoperative re adhesion, but the effect of different devices is different.
Therefore, this study was conducted.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
The Foley catheter is usually inserted into the uterine after a hysteroscopic adhesiolysis and removed after on the 5-7th day after surgery.
Several investigators demonstrated its favorable effect in the recurrence of adhesion after the treatment of intrauterine adhesion.
Disposable balloon uterine stent is specially designed to fit into the cavity of the uterus, and usually removed on the 7th day after surgery.
Study Type
Interventional
Enrollment (Anticipated)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Zhu Ru, MD
- Phone Number: +8613966636438
- Email: zhuru19790202@163.com
Study Contact Backup
- Name: Wang Sha, MD
- Phone Number: +8615201556908
- Email: wangsha1020@163.com
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100006
- Recruiting
- Beijing Obstetrics and Gynecology Hospital,Capital Medical University
-
Contact:
- Liu Zhen
- Phone Number: +8613718210767
- Email: fcyykyb@163.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 38 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- age 20-40 years;
- Moderate to severe intrauterine adhesion (AFS score ≥5);
- complains of menstruation disorder and reproductive dysfunction
- Agreement to have second-look hysteroscopy
- informed consent
Exclusion Criteria:
- ovarian failure
- patients who did not proceed to second-look hysteroscopy within the specified time frame
- Contraindication of hormone
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Foley catheter
After the completion of hysteroscopic adhesiolysis, Foley catheter was inserted and inflated with normal saline which was removed on the 7th day after surgery.
|
Foley catheter can partly separate the sides of uterus wall.
|
Experimental: Disposable balloon uterine stent
After the completion of hysteroscopic adhesiolysis, disposable balloon uterine stent was inserted and inflated with normal saline which was removed on the 7th day after surgery.
|
The disposable balloon uterine stent is heart-shaped that resembled the shape of the uterine cavity and could fully separate the two sides of the uterine wall and the corners of the uterus compare to Foley catheter
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
second diagnostic hysteroscopy
Time Frame: Within the first 3 months after surgery
|
AFS score(The American Fertility Society classifications)
|
Within the first 3 months after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Menstruation Pattern
Time Frame: Within the first 3 months after surgery
|
Improvement or No Significant Change
|
Within the first 3 months after surgery
|
Number of participants with pregnancy
Time Frame: one year
|
Number of biochemical pregnancies and clinical pregnancies
|
one year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Duan Hua, PhD, Beijing Obstetrics and Gynecology Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 23, 2017
Primary Completion (Anticipated)
August 20, 2018
Study Completion (Anticipated)
October 20, 2018
Study Registration Dates
First Submitted
October 18, 2017
First Submitted That Met QC Criteria
October 31, 2017
First Posted (Actual)
November 6, 2017
Study Record Updates
Last Update Posted (Actual)
November 6, 2017
Last Update Submitted That Met QC Criteria
October 31, 2017
Last Verified
October 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- No.3-20140601
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intrauterine Adhesion
-
Hua DuanRecruitingIntrauterine Adhesion | Database for Intrauterine Adhesion | Risk Factors for Intrauterine Adhesion | Risk Stratification and Prognostic AssessmentChina
-
The Fourth Affiliated Hospital of Zhejiang University...Recruiting
-
Rejoni Inc.CompletedIntrauterine AdhesionUnited States
-
Ain Shams Maternity HospitalCompletedIntrauterine AdhesionEgypt
-
Fu Xing Hospital, Capital Medical UniversityBeijing Tiantan HospitalUnknown
-
Rejoni Inc.RecruitingIntrauterine AdhesionUnited States
-
Limin FengRecruitingIntrauterine AdhesionChina
-
Fu Xing Hospital, Capital Medical UniversityRecruitingIntrauterine AdhesionChina
-
Second Affiliated Hospital, School of Medicine,...Shanghai iCELL Biotechnology Co., Ltd, Shanghai, ChinaRecruitingIntrauterine AdhesionChina
-
WomedCompletedIntrauterine AdhesionBelgium, France, Netherlands
Clinical Trials on Foley catheter
-
Northwestern UniversityTerminated
-
The University of Texas Medical Branch, GalvestonActive, not recruitingLabor Induction | Early AmniotomyUnited States
-
Tyco Healthcare GroupCompletedUrinary Tract InfectionsUnited States
-
University of Alabama at BirminghamCompletedCervical Ripening | Labor InductionUnited States
-
The Cleveland ClinicWake Forest University Health SciencesUnknownPelvic Organ Prolapse | Surgery | Urinary Incontinence,StressUnited States
-
HaEmek Medical Center, IsraelCompletedSingle Balloon Catheter Compared With Double Balloon Catheter for Ripening of the Unfavorable CervixInduction of LaborIsrael
-
Rush University Medical CenterCompletedTotal Knee Arthroplasty | Postoperative Urinary Retention | Total Hip ArthroplastyUnited States
-
Rambam Health Care CampusCompleted
-
Kanuni Sultan Suleyman Training and Research HospitalUnknown